Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Intravenous interferon administered during liver transplantation is not effective in preventing hepatitis C reinfection.

Digestive diseases and sciences - 1 Oct 2013

Russo Mark W, Narang Tarun, Eskind Lon, Hayes Daniel, Casingal Vincent, Purdum Preston P, Hanson John S, Ahrens Will, Norton James, Bonkovsky Herbert

Abstract excerpt

BACKGROUND: Post-transplant hepatitis C is a major challenge after liver transplantation (LT). Antiviral therapy is associated with lower efficacy in the post-transplant setting. AIMS: The purpose of this study was to determine the safety and effect of intravenous interferon (IFN) during the anhepatic phase of LT on hepatitis C viral load. METHODS: Fifteen consecutive subjects undergoing liver transplant for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Intravenous
Share to Hepatitis C

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Liver Transplantation

Share to Polyethylene Glycols

Share to Secondary Prevention

Share to Viral Load

Source

Identifiers

PMID: 23812862
DOI: 10.1007/s10620-013-2749-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Intravenous interferon administered during liver transplantation is not effective in preventing hepatitis C reinfection.PMID 23812862Read ↗

Hepatitis C virus in the transplant setting.Semantic proximity Read ↗

Management of hepatitis C after transplantation: a long way from success.Semantic proximity Read ↗

Antiviral prophylactic intervention for chronic hepatitis C virus in patients undergoing liver transplantation.Semantic proximity Read ↗

Long-term outcome of hepatitis C virus infection after liver transplantation.Semantic proximity Read ↗

Pegylated interferon for recurrent hepatitis C in liver transplant recipients with renal failure: a prospective cohort study.Semantic proximity Read ↗

A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation.Semantic proximity Read ↗

Use of a hepatitis C virus (HCV) RNA-positive donor in a treated HCV RNA-negative liver transplant recipient.Semantic proximity Read ↗

Antiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver transplantation.Semantic proximity Read ↗

Daily interferon therapy for hepatitis C virus infection in liver transplant recipients.Semantic proximity Read ↗

The benefits of interferon treatment in patients without sustained viral response after living donor liver transplantation for hepatitis C.Semantic proximity Read ↗

Treatment of recurrent HCV infection following liver transplantation: results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNα-2a plus ribavirin.Semantic proximity Read ↗

Safety and anti-HCV effect of prolonged intravenous silibinin in HCV genotype 1 subjects in the immediate liver transplant period.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.